Racial differences seen in prostate cancer care quality

Black men with newly diagnosed prostate cancer have lower odds of overtreatment and confirmatory testing when compared with white men, according to a research letter published online in JAMA Network Open.

Hormone-free male contraceptive pill passes first safety test

A potential new male contraceptive drug has just undergone its first tests in human volunteers. The results give the first indication that the drug, which does not use artificial hormones or affect testosterone production ...

page 33 from 37